Thursday, September 13, 2007
An Attorney General, A Genetic Counselor and Gap Phase
Posted by
Steve Murphy MD
at
4:47 PM
3
comments
Labels: 23andme, drudgereport, george church, Myriad, navigenics, personal genome project, pfizer, pharmacogenomics
Tuesday, September 11, 2007
NYT and WSJ cover Myriad's campaign
What test characteristics favor possible approval of an OTC home-use HIV test?
• The test is simple to use compared to other types of HIV tests and earlier versions of rapid HIV tests, suggesting that untrained persons will be able to perform the test properly.
• The test does not require special storage conditions.
The most interesting one was......
• Informational materials supplied with the test are sufficient to provide adequate information to potential users on performing the test and to substitute for live counseling.
Posted by
Steve Murphy MD
at
4:21 PM
2
comments
Labels: Breast cancer, direct to consumer, DTC testing, genetic testing, Myriad
Sunday, September 9, 2007
Gene Genie and George's Blog
Posted by
Steve Murphy MD
at
6:31 PM
0
comments
Labels: gene genie, george church, personal genome project, personalized medicine
Saturday, September 8, 2007
Genomics as a Lifestyle
Posted by
Steve Murphy MD
at
6:48 AM
0
comments
Thursday, September 6, 2007
LRP8 and Familial MI....Ho Hum

This month in the American Journal of Human Genetics we have some interesting publications. Including an association study identifying a gene known as LRP8. So what is LRP8? It is a receptor for bad cholesterol. When bad cholesterol binds this receptor, platelets (the bricks in your blood that build a clot) become sticky making it easier to thrombose (form a clot).
I am interested in this study for several reasons. First, it has been shown that platelets get stick even after ingesting a Big Mac. That's correct. Just one fast food hamburger can theoretically precipitate a heart attack. So naturally we would love to know who. Think Personalized Diet/Nutrigenomics. I wonder if Salugen can hear me now? I still haven't received their "Scientific Data" yet. I will publicize it if they do.
Back to the study. So what was studied is a group called the GeneQuest families of familial MI, the control group was some white men who were given cardiac catheterization and found to have no atherosclerosis burden (OOPS). Well, that control does not mean they did not have atherosclerotic burden, because catheterization cannot identify 30% occluded vessel plaques.
In addition their findings were replicated on an Italian cohort of familial heart attack as well. So why do I say Ho Hum?
Let's see: No Odds Ratio was greater than 1.43 This 43% increase in heart attack and coronary artery disease is still less than the family history risk itself. The only good thing was that this risk persisted even when controlling for plasma total cholesterol levels, triglyceride levels, hypertension, and diabetes, in addition to age and sex.
What is your odds ratio for heart attack if your father had one prior to 65?
The Answer: 5.8 according to Maren Scheuner's article on familial risk for MI.
Do you now see why I say HO HUM about this gene? When will we see the gene card panel for MI??????
The Sherpa Says: Listen to all of this hulabaloo about Ventner's Genome. Even Men's Health magazine says you should bank your parents DNA if they die. What good is all of this if we don't have a key to the map? The map will make no sense! LRP8, APOE4, I could go on and on. What good is a genome map, without a guide? What good is the guide without the studies? Why did you buy the iPOD early, only to have late adopters get it cheaper? For the rebate? Doubtful. This is why primary care physicians are late adopters. If you want to get your genome (and I do) then you better be prepared to find someone who will help you understand it...becasue cliff notes, or Navigenics just won't do. Nor will scarfing down Big Macs....
Posted by
Steve Murphy MD
at
4:36 PM
1 comments
Labels: 100 genomes, 23andme, Craig Venter genes, craig ventner genome, dnadirect, google, james watson, navigenics
Wednesday, September 5, 2007
1000 Genomes???? Coming Soon.
Kathy Siminovitch, director of genomic medicine at Toronto's Mount Sinai Hospital and the Samuel Lunenfeld Research Institute, noted that the first Human Genome Project rang in at roughly $1-billion (U.S). But with the new generation of "ultra-fast" DNA sequencing machines that have hit the market within the past two years, she said the bill is expected to drop to less than $100,000 by year's end.
Posted by
Steve Murphy MD
at
4:30 PM
0
comments
Labels: Craig Venter genes, DNA direct, Eye on DNA, genetic discrimination, genetic testing, Helix Health of Connecticut, personal genome project
Saturday, September 1, 2007
Pilot study...Buy Stock in Kimball Genetics now!
- Negative articles get print (contrarians always get published)
- The doubters often have no genetic training (or combined with internal medicine) and are afraid of what they may have to do if Personalized Medicine succeeds (Which it will)
- Their idea of Personalized Medicine is the snazzy websites of certain whole genome analysis, DTC testing or nutrigenomic fly by the night companies. Which are BTW putting a horrible stain on the name of Personalized Medicine. Francis Collins recently said "over promising can often kill a movement" so stop it. Or at least don't over promise. Please, I beg you.
"this study has other limitations. First, our study population consisted entirely of patients initiating warfarin for deep vein thrombosis prophylaxis following total hip or knee arthroplasty. The ability to generalize our model for other indications is unknown and should be studied in a broad population. In particular, the appropriate starting doses and the ability to safely initiate warfarin without genetic information need to be examined in other patient groups—including nonsurgical populations"
Posted by
Steve Murphy MD
at
4:15 PM
0
comments
Labels: 23andme, blood clot, coumadin, DNA direct, gene tests, logarithm, navigenics, warfarin





